WallStSmart

The Joint Corp (JYNT)vsTenet Healthcare Corporation (THC)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Tenet Healthcare Corporation generates 37154% more annual revenue ($21.81B vs $58.55M). THC leads profitability with a 10.3% profit margin vs 6.5%. THC appears more attractively valued with a PEG of 1.82. THC earns a higher WallStSmart Score of 74/100 (B).

JYNT

Hold

49

out of 100

Grade: D+

Growth: 6.0Profit: 5.0Value: 3.0Quality: 6.5
Piotroski: 6/9Altman Z: 0.90

THC

Strong Buy

74

out of 100

Grade: B

Growth: 6.7Profit: 8.0Value: 6.3Quality: 4.5
Piotroski: 4/9Altman Z: 1.73

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

JYNT3 strengths · Avg: 9.3/10
EPS GrowthGrowth
653.0%10/10

Earnings expanding 653.0% YoY

Return on EquityProfitability
20.9%9/10

Every $100 of equity generates 21 in profit

Debt/EquityHealth
0.139/10

Conservative balance sheet, low leverage

THC3 strengths · Avg: 10.0/10
P/E RatioValuation
10.1x10/10

Attractively priced relative to earnings

Return on EquityProfitability
48.1%10/10

Every $100 of equity generates 48 in profit

EPS GrowthGrowth
213.4%10/10

Earnings expanding 213.4% YoY

Areas to Watch

JYNT4 concerns · Avg: 2.8/10
Market CapQuality
$114.56M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
6.5%3/10

6.5% margin — thin

Operating MarginProfitability
3.3%3/10

Operating margin of 3.3%

PEG RatioValuation
8.832/10

Expensive relative to growth rate

THC3 concerns · Avg: 3.0/10
PEG RatioValuation
1.824/10

Expensive relative to growth rate

Altman Z-ScoreHealth
1.734/10

Distress zone — elevated risk

Debt/EquityHealth
2.841/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : JYNT

The strongest argument for JYNT centers on EPS Growth, Return on Equity, Debt/Equity. Revenue growth of 14.4% demonstrates continued momentum.

Bull Case : THC

The strongest argument for THC centers on P/E Ratio, Return on Equity, EPS Growth.

Bear Case : JYNT

The primary concerns for JYNT are Market Cap, Profit Margin, Operating Margin. A P/E of 57.9x leaves little room for execution misses.

Bear Case : THC

The primary concerns for THC are PEG Ratio, Altman Z-Score, Debt/Equity. Debt-to-equity of 2.84 is elevated, increasing financial risk.

Key Dynamics to Monitor

THC carries more volatility with a beta of 1.23 — expect wider price swings.

JYNT is growing revenue faster at 14.4% — sustainability is the question.

THC generates stronger free cash flow (417M), providing more financial flexibility.

Monitor MEDICAL CARE FACILITIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

THC scores higher overall (74/100 vs 49/100). Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

The Joint Corp

HEALTHCARE · MEDICAL CARE FACILITIES · USA

The Joint Corp. The company is headquartered in Scottsdale, Arizona.

Visit Website →

Tenet Healthcare Corporation

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Tenet Healthcare Corporation is a diversified health services company. The company is headquartered in Dallas, Texas.

Want to dig deeper into these stocks?